ArticleJACC. Case reports2025
Eosinophilic Myocarditis Associated With Chronic Eosinophilic Leukemia.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEosinophilic myocarditis (EM) is a rare, dangerous complication of eosinophil-predominant disease. Its presentation varies greatly, with detrimental consequences including arrhythmia, heart failure, and sudden cardiac death. CASE SUMMARY: A 58-year-old woman with chronic eosinophilic leukemia presented with worsening dyspnea and was found to have EM and left ventricular apical thrombus based on characteristic imaging findings. She was started on a heparin drip, corticosteroids, imatinib, and furosemide. She did not experience complications of myocarditis while admitted, and biventricular function was preserved. DISCUSSION: There is a paucity of established guidelines regarding the diagnosis of EM. However, there may be a crucial role for imaging modalities in workup and diagnosis, one that may save patients from invasive procedures. TAKE-HOME MESSAGES: This case highlights the utility of noninvasive imaging as well as the importance of early recognition and multidisciplinary management. Clinicians should consider EM as part of the differential diagnosis when managing patients with eosinophilia and signs of cardiomyopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.